Get started
Author

Germán Peña

Observed names: German E Pena, German E. Pena, German Pena
OpenAlex ID: A5013753665
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
2024 · Arnon P Kater, Önder Arslan, et al. · The Lancet Oncology · 46
PDF
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study
2024 · Marco Herling, Claire Dearden, et al. · Blood Advances · 7
PDF
Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax in the Clinical Trial and Post-Marketing Settings
2020 · John F. Seymour, John G. Gribben, et al. · Blood · 5
Attainment of Complete Remission Is Significantly Associated with Longer Survival Outcomes in Relapsed/Refractory (R/R) CLL: A Meta-Analysis
2016 · Varun Ektare, Christopher P. Fox, et al. · Blood · 3
Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel Therapies
2019 · Anthony R. Mato, Kavita Sail, et al. · Blood · 2
Mitigation of tumor lysis syndrome (TLS) complications with venetoclax (VEN) in CLL.
2018 · Matthew Steven Davids, John Francis Seymour, et al. · Journal of Clinical Oncology · 1
Venetoclax Effectiveness, Safety, and Treatment Patterns in Chronic Lymphocytic Leukemia Patients: Results from the CLL Collaborative Study of Real-World Evidence (CORE)
2020 · Dandan Zheng, Kavita Sail, et al. · Blood
Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study
2019 · Mazyar Shadman, Kavita Sail, et al. · Blood
Venetoclax for chronic lymphocytic leukemia: baseline characteristics and safety data from pre-approval cohort programs in the EU
2017 · B Eichhorst, Edurne Arriola, et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
RANO, más que ficción.
2013 · Nicolás Useche, Sonia Bermúdez, et al. · Revista Colombiana de Hematología y Oncología
PDF
Análisis de la codeleción 1p19q como marcador pronóstico en pacientes con glioblastoma primario.
2012 · Andrés Felipe Cardona, León Darío Ortiz, et al. · Revista Colombiana de Hematología y Oncología
PDF
Works count: 11
Citation count: 64
H-index: 3
I10-index: 1
Year
Topic
Type